Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXN | AZN | AMGN | GILD | BMY |
| Company | Alexion Pharm Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 181.04 | 190.46 | 369.99 | 149.69 | 60.00 |
| High | 182.67 | 193.97 | 381.64 | 153.13 | 62.05 |
| Low | 180.13 | 188.49 | 368.90 | 148.71 | 59.77 |
| Latest | 182.50 | 193.67 | 382.74 | 152.90 | 61.79 |
| Change | +3.05 | +6.51 | +14.94 | +3.53 | +2.27 |
| % Change | +1.70% | +3.48% | +4.06% | +2.36% | +3.81% |
| Volume | 90,506,096 | 2,551,377 | 2,099,589 | 5,591,409 | 11,992,037 |
| 20-Day Average Volume | 8,395,359 | 4,802,686 | 2,991,080 | 8,002,563 | 13,205,491 |
| Previous Close | 179.45 | 187.16 | 367.80 | 149.37 | 59.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 183.19 | 187.17 | 342.90 | 134.54 | 55.99 |
| 20-Day Raw Stochastic | 44.63% | 99.62% | 98.83% | 99.72% | 98.47% |
| 20-Day Relative Strength | 55.14 | 59.26 | 70.72 | 77.28 | 73.53 |
| Weighted Alpha | +62.81 | +40.31 | +39.58 | +66.98 | +23.49 |
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.87% since 07/13/21 | +4.50% since 01/30/26 | +11.42% since 01/30/26 | +7.81% since 01/30/26 | +12.48% since 01/30/26 |
| Low | 178.51 on 07/19/21 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 140.01 on 02/02/26 | 54.96 on 02/02/26 |
| High | 187.45 on 07/14/21 | 193.95 on 02/06/26 | 381.64 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +1.00% since 06/18/21 | +2.09% since 01/06/26 | +15.37% since 01/06/26 | +26.10% since 01/06/26 | +13.78% since 01/06/26 |
| Low | 178.51 on 07/19/21 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 187.45 on 07/14/21 | 193.95 on 02/06/26 | 381.64 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +9.58% since 04/20/21 | +15.73% since 11/06/25 | +20.70% since 11/06/25 | +24.02% since 11/06/25 | +32.79% since 11/06/25 |
| Low | 164.83 on 04/29/21 | 168.44 on 11/07/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 187.45 on 07/14/21 | 193.95 on 02/06/26 | 381.64 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +15.70% since 01/20/21 | +31.72% since 08/06/25 | +33.81% since 08/06/25 | +38.77% since 08/06/25 | +38.15% since 08/06/25 |
| Low | 146.97 on 03/04/21 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 187.45 on 07/14/21 | 193.95 on 02/06/26 | 381.64 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 40,335,968 | 290,267,936 | 198,053,312 | 185,320,384 | 121,168,016 |
| Shares Outstanding, K | 221,019 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 6,069,900,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | 603,400,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 1,636,500,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | 636,000,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.25 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 3.52 on 04/30/21 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 07/29/21 | 02/10/26 | 05/07/26 | 02/10/26 | 02/05/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 15.07 | 20.51 | 16.76 | 17.85 | 8.78 |